SCHEMBL751758

SCHEMBL751758

CC(C)[Si](Cc1ccccc1)([N-][Si](Cc1ccccc1)(C(C)C)C(C)C)C(C)C.[Na+]

nearest known ligand 0.41

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A known ✓ P29274 1/20 0.39
▸ ADORA1 known ✓ P30542 1/20 0.39
▸ TAAR1 Q96RJ0 5/20 0.39
▸ SLC6A2 P23975 4/20 0.39
▸ SIGMAR1 Q99720 4/20 0.39
▸ SLC6A4 P31645 2/20 0.39
▸ SLC6A3 Q01959 2/20 0.39
▸ MAOA P21397 1/20 0.39
▸ CYP2A6 P11509 1/20 0.39
▸ SLC18A2 Q05940 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ TRPA1 O75762 3/20 0.36
▸ TSHR P16473 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAOB P27338 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ ADRA1A P35348 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL752620 0.96 TAAR1 (0.39) TAAR1SLC6A2SIGMAR1SLC6A4SLC6A3
Potassium Ion SCHEMBL754107 0.96 TAAR1 (0.39) TAAR1SLC6A2SIGMAR1SLC6A4SLC6A3
SCHEMBL18221776 0.74 TAAR1 (0.41) TAAR1SLC6A2SIGMAR1SLC6A4SLC6A3
SCHEMBL16369340 0.73 TAAR1 (0.44) TAAR1SLC6A2SIGMAR1SLC6A4SLC6A3
SCHEMBL987730 0.73 TAAR1 (0.44) TAAR1SLC6A2SIGMAR1SLC6A4SLC6A3
SCHEMBL752649 0.73 TP53 (0.42) TAAR1SLC6A2SLC6A4SLC6A3MAOA
SCHEMBL2018585 0.70 TSHR (0.42) TAAR1SLC6A2SIGMAR1SLC6A4SLC6A3
Potassium Ion SCHEMBL752477 0.69 TP53 (0.42) TAAR1SLC6A2SLC6A4SLC6A3MAOA
Lithium Ion SCHEMBL751524 0.69 TP53 (0.42) TAAR1SLC6A2SLC6A4SLC6A3MAOA
SCHEMBL816643 0.69 TP53 (0.42) TAAR1SLC6A2SLC6A4SLC6A3MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10611775-B2 Thiophene derivatives TIANJIN HEMAY PHARMACEUTICAL CO., LTD. (CN) 2020-04-07 — — US disclosed
US-20190322684-A1 THIOPHENE DERIVATIVES TIANJIN HEMAY PHARMACEUTICAL CO., LTD. (CN) 2019-10-24 — — US disclosed
US-10385062-B2 Thiophene derivatives TIANJIN HEMAY BIO-TECH CO., LTD. (CN) 2019-08-20 — — US disclosed
US-20170197982-A1 THIOPHENE DERIVATIVES GANZHOU HEMAY PHARMACEUTICAL CO., LTD. (CN) 2017-07-13 — — US disclosed
US-9630975-B2 Thiophene derivatives TIANJIN HEMAY BIO-TECH CO., LTD. (CN) 2017-04-25 — — US disclosed
US-8952178-B2 Thiophene derivatives TIANJIN HEMAY BIO-TECH CO., LTD. (CN) 2015-02-10 — — US disclosed
US-20140255342-A1 THIOPHENE DERIVATIVES TIANJIN HEMAY BIO-TECH CO., LTD. (CN) 2014-09-11 — — US disclosed
EP-2431371-B1 THIOPHENE DERIVATIVES TIANJIN HEMAY BIO TECH CO LTD (CN) 2013-10-09 — — EP disclosed
US-20120107269-A1 THIOPHENE DERIVATIVES Tianjin Hemay Biotech Co., Ltd (CN) 2012-05-03 — — US disclosed
EP-2431371-A1 THIOPHENE DERIVATIVES Tianjin Hemay Bio-Tech Co., Ltd. (CN) 2012-03-21 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10385062-B2 Thiophene derivatives TSHR, RB1, TAS2R7 ADORA2A 713/4885ADORA1 668/4885TAAR1 85/4885
US-20120107269-A1 THIOPHENE DERIVATIVES TSHR, RB1, TAS2R7 ADORA2A 713/4885ADORA1 668/4885TAAR1 85/4885
US-10611775-B2 Thiophene derivatives TSHR, RB1, TAS2R7 ADORA2A 713/4885ADORA1 668/4885TAAR1 85/4885
US-20170197982-A1 THIOPHENE DERIVATIVES TSHR, RB1, TAS2R7 ADORA2A 713/4885ADORA1 668/4885TAAR1 85/4885
US-20140255342-A1 THIOPHENE DERIVATIVES TSHR, RB1, TAS2R7 ADORA2A 713/4885ADORA1 668/4885TAAR1 85/4885
US-20190322684-A1 THIOPHENE DERIVATIVES TSHR, RB1, TAS2R7 ADORA2A 713/4885ADORA1 668/4885TAAR1 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback